{"blog": [], "keywords": [{"value": "Teva Pharmaceutical Industries Ltd", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Cephalon Inc", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Generic Brands and Products", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Federal Trade Commission", "name": "organizations", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/04/21/business/teva-to-pay-512-million-to-settle-suit-over-delay-of-sleep-disorder-drug.html", "document_type": "article", "byline": {"person": [{"lastname": "THOMAS", "firstname": "Katie", "role": "reported", "organization": "", "rank": 1}], "original": "By KATIE THOMAS"}, "type_of_material": "News", "multimedia": [{"url": "images/2015/04/21/business/21SETTLE/21SETTLE-thumbWide.jpg", "legacy": {"wide": "images/2015/04/21/business/21SETTLE/21SETTLE-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2015/04/21/business/21SETTLE/21SETTLE-articleLarge.jpg", "legacy": {"xlarge": "images/2015/04/21/business/21SETTLE/21SETTLE-articleLarge.jpg", "xlargeheight": "400", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 400}, {"url": "images/2015/04/21/business/21SETTLE/21SETTLE-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/04/21/business/21SETTLE/21SETTLE-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "572", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "A lawsuit claimed that Cephalon, a subsidiary of Teva Pharmaceuticals, had paid generic manufacturers to keep a cheaper version of a drug off the market.", "pub_date": "2015-04-21T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug", "main": "Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug"}, "print_page": "6", "snippet": "A lawsuit claimed that Cephalon, a subsidiary of Teva Pharmaceuticals, had paid generic manufacturers to keep a cheaper version of a drug off the market.", "_id": "5535a20c38f0d821accece45", "slideshow_credits": null, "abstract": "Teva Pharmaceutical Industries announces settlement of $512 million over claims by drug wholesalers and other companies that subsidiary Cephalon paid generic manufacturers to keep their cheaper versions of drug off market; settlement, largest ever paid to direct purchasers of drugs, must be approved by judge."}